Heres a quick comparison of the two: FDA Approval and Medical Uses Regulatory decisions play a big role in how medications are prescribed and who they are intended for
However, since oral glutathione already has very limited bioavailability due to enzymatic hydrolysis in the gut, any additional delay in gastric emptying is unlikely to produce a clinically meaningful difference in how much reaches your bloodstream
Your price won't increase as your dose increases, removing a financial barrier to finding your optimal therapeutic window
[3] Epitalon reduced the number of spontaneous tumors and the number of metastases in mice that did develop spontaneous tumors in an experiment on one-year-old female mice of the C3H/He inbred strain, and is speculated to have oncostatic and anti-metastatic properties
Typically, the manufacturer savings card is designed for patients with commercial insurance that *covers* the drug but leaves a high co-pay
A COA provides batch-specific analytical information, including purity, identification, batch number, and quality-control results
